Gradient Investments’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.9M | Buy |
+38,013
| New | +$16.9M | 0.31% | 103 |
|
|
2024
Q3 | – | Sell |
-38
| Closed | -$17.8K | – | 1278 |
|
|
2024
Q2 | $17.8K | Hold |
38
| – | – | ﹤0.01% | 655 |
|
|
2024
Q1 | $15.9K | Sell |
38
-116
| -75% | -$48.5K | ﹤0.01% | 586 |
|
|
2023
Q4 | $62.7K | Sell |
154
-25
| -14% | -$10.2K | ﹤0.01% | 500 |
|
|
2023
Q3 | $62.2K | Buy |
179
+157
| +714% | +$54.6K | ﹤0.01% | 460 |
|
|
2023
Q2 | $7.74K | Buy |
22
+10
| +83% | +$3.52K | ﹤0.01% | 859 |
|
|
2023
Q1 | $3.78K | Buy |
12
+5
| +71% | +$1.58K | ﹤0.01% | 999 |
|
|
2022
Q4 | $2.02K | Buy |
+7
| New | +$2.02K | ﹤0.01% | 1085 |
|
|
2021
Q4 | – | Sell |
-3
| Closed | -$1K | – | 1335 |
|
|
2021
Q3 | $1K | Sell |
3
-18
| -86% | -$6K | ﹤0.01% | 1116 |
|
|
2021
Q2 | $4K | Sell |
21
-5
| -19% | -$952 | ﹤0.01% | 922 |
|
|
2021
Q1 | $6K | Sell |
26
-3,315
| -99% | -$765K | ﹤0.01% | 863 |
|
|
2020
Q4 | $909K | Sell |
3,341
-113
| -3% | -$30.7K | 0.04% | 162 |
|
|
2020
Q3 | $940K | Sell |
3,454
-3,096
| -47% | -$843K | 0.04% | 162 |
|
|
2020
Q2 | $1.9M | Sell |
6,550
-989
| -13% | -$287K | 0.09% | 141 |
|
|
2020
Q1 | $1.79M | Buy |
7,539
+893
| +13% | +$213K | 0.1% | 135 |
|
|
2019
Q4 | $1.46M | Sell |
6,646
-265
| -4% | -$58K | 0.06% | 169 |
|
|
2019
Q3 | $1.17M | Buy |
6,911
+835
| +14% | +$141K | 0.06% | 182 |
|
|
2019
Q2 | $1.11M | Buy |
+6,076
| New | +$1.11M | 0.06% | 180 |
|
|
2018
Q1 | – | Sell |
-13
| Closed | -$2K | – | 1174 |
|
|
2017
Q4 | $2K | Buy |
+13
| New | +$2K | ﹤0.01% | 838 |
|